GTLB Options for December 19th Now Available for Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 09 2025
0mins
Should l Buy GTLB?
Source: NASDAQ.COM
Put Contract Analysis: The $42.50 put contract for GitLab Inc (GTLB) has a bid of $2.95, allowing investors to potentially buy shares at a 10% discount to the current price of $47.34, with a 70% chance of expiring worthless, offering a 6.94% return on cash commitment if it does.
Call Contract Strategy: The $50.00 call contract has a bid of $4.50, providing a potential 15.12% return if the stock is called away, with a 50% chance of expiring worthless, which would yield a 9.51% additional return if the investor retains their shares.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GTLB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GTLB
Wall Street analysts forecast GTLB stock price to rise
24 Analyst Rating
13 Buy
10 Hold
1 Sell
Moderate Buy
Current: 26.700
Low
34.00
Averages
50.86
High
72.00
Current: 26.700
Low
34.00
Averages
50.86
High
72.00
About GTLB
GitLab Inc. provides DevSecOps Platform, is built on a single codebase, unified data model, and user interface. The Company offers customers flexible deployment options, including a self-managed offering, as well as multi-tenant and single-tenant (GitLab Dedicated) software-as-a-service (SaaS) solutions. It offers the DevSecOps Platform in three different subscription tiers, namely Free, Premium and Ultimate. The DevSecOps Platform enables its customers to move their DevOps workflow across any hybrid or multi-cloud environment. Its subscription plans are available as a self-managed offering that customers download to run in their own on-premises environment or hybrid cloud environments, and also a SaaS offering, which is offered as either multi-tenant or single-tenant (called GitLab Dedicated). The Company also provides related training and professional services. Its SaaS products provide access to hosted software as well as support.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
GitLab Reports Strong Q4 2026 Earnings with $1B ARR
- Annual Revenue Growth: GitLab achieved $955 million in revenue for FY 2026, reflecting a 26% year-over-year increase, with a non-GAAP operating margin of 17%, up approximately 680 basis points, indicating significant improvement in profitability.
- Cash Flow and Buyback Plan: The company generated $220 million in free cash flow in Q4, an increase of over 80%, while announcing a $400 million share repurchase program, demonstrating management's confidence in future growth prospects.
- Customer Expansion and Retention: GitLab added the highest number of million-dollar customers in its history during Q4, with a dollar-based net retention rate of 118%, showcasing strong enterprise expansion despite pressures in the price-sensitive customer segment.
- Future Outlook and Strategy: Management projects total revenue for FY 2027 to be between $1.099 billion and $1.118 billion, representing approximately 15% to 17% growth, and emphasizes a focus on executing new monetization strategies and scaling sales capacity to navigate market challenges.
See More
OpenAI Reportedly Building Internal Code Repository to Compete with GitHub
- Internal Repository Development: OpenAI is reportedly developing an internal code repository platform to lessen its reliance on Microsoft’s GitHub, a move partly triggered by recent outages that hindered developers' collaboration for hours, impacting project timelines and efficiency.
- Increased Market Competition: The project is still in its early stages and may take months to complete; if commercialized, it could position OpenAI in direct competition with Microsoft's developer ecosystem, despite their broader partnership.
- GitLab Earnings Performance: GitLab reported Q4 adjusted earnings of $0.30 per share, exceeding analyst expectations of $0.23, with revenue rising 23% year-over-year to $260.4 million, indicating strong growth in revenue generation.
- Cautious Future Outlook: Although GitLab's FY2026 revenue reached $955.2 million, up 26% from the previous year, its FY2027 adjusted earnings forecast of $0.76 to $0.80 per share is significantly below the consensus estimate of $1.03, leading to a decline in investor sentiment.
See More
GitLab's Fiscal 2027 Guidance Falls Short of Expectations
- Earnings Beat: GitLab reported adjusted EPS of $0.30 for Q4 FY2026, exceeding the $0.23 consensus estimate, with revenue rising 23% year-over-year to $260.4 million, indicating strong performance in the software development sector.
- Disappointing Guidance: The company projects FY2027 revenue midpoint at $1.11 billion, a 16% increase year-over-year, but below the $1.13 billion consensus, reflecting challenges in future growth prospects.
- Gross Margin Decline: GitLab anticipates a slight decline in gross margin for FY2027, expected to range from 85% to 87%, down from 89% in FY2026, which may affect investor confidence.
- Analyst Rating Adjustments: Several financial firms have lowered their price targets for GitLab, with Needham reducing its target from $50 to $32, indicating a cautious market outlook on the company's future growth despite maintaining a Buy rating.
See More
STAAR Surgical Reports Disappointing Q4 Results, Shares Plummet
- Disappointing Earnings: STAAR Surgical reported a fourth-quarter loss of $0.13 per share, significantly missing the analyst consensus estimate of a $0.06 profit, indicating major challenges in profitability.
- Sales Decline: The company's quarterly sales totaled $57.801 million, falling short of the analyst consensus estimate of $75.370 million, reflecting weak market demand and increased competitive pressure.
- Stock Reaction: In pre-market trading, STAAR Surgical's shares dropped 10.2% to $16.99, indicating investor concerns about the company's future prospects following the disappointing earnings report.
- Market Impact: This earnings report not only affects STAAR Surgical's stock price but may also negatively impact its market position in the medical device industry, prompting investors to monitor potential strategic adjustments going forward.
See More
GitLab Reports Strong Q4 but Weak FY2027 Guidance
- Strong Earnings Report: GitLab's Q4 EPS of 30 cents exceeded the consensus estimate of 23 cents, with revenue of $260.4 million growing 23% year-over-year, indicating robust performance in customer acquisition and revenue generation.
- Significant Customer Growth: The number of clients generating over $1 million in ARR rose 26% year-over-year to 155, demonstrating GitLab's success in attracting high-value customers and solidifying its market position.
- Weak Guidance Outlook: Despite achieving $955.2 million in revenue for FY2026, up 26%, the company's guidance for FY2027 adjusted EPS of 76 to 80 cents falls well below the $1.05 analyst estimate, leading to a bearish market sentiment.
- Stock Under Pressure: GitLab shares fell 9.85% to $24.07 in premarket trading, nearing a 52-week low of $23.45, reflecting investor concerns about future growth, with technical indicators suggesting a bearish trend in the short term.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, reflecting varying market perspectives that could influence investor decisions and market trends.
- Investor Focus: Analysts' opinions are particularly crucial when considering the purchase of SMTC stock, as these insights may affect investor confidence and willingness to buy, directly impacting stock prices.
- Source of Updates: A complete view of all analyst rating changes, including upgrades and downgrades, can be found on our analyst ratings page, providing a comprehensive perspective to help investors make informed decisions.
- Market Dynamics Impact: The adjustments in analysts' ratings not only reflect views on company fundamentals but may also influence overall market sentiment, subsequently affecting trading volumes and price fluctuations of related stocks.
See More
GitLab Reports Strong Q4 2026 Earnings with $1B ARR
- Annual Revenue Growth: GitLab achieved $955 million in revenue for FY 2026, reflecting a 26% year-over-year increase, with a non-GAAP operating margin of 17%, up approximately 680 basis points, indicating significant improvement in profitability.
- Cash Flow and Buyback Plan: The company generated $220 million in free cash flow in Q4, an increase of over 80%, while announcing a $400 million share repurchase program, demonstrating management's confidence in future growth prospects.
- Customer Expansion and Retention: GitLab added the highest number of million-dollar customers in its history during Q4, with a dollar-based net retention rate of 118%, showcasing strong enterprise expansion despite pressures in the price-sensitive customer segment.
- Future Outlook and Strategy: Management projects total revenue for FY 2027 to be between $1.099 billion and $1.118 billion, representing approximately 15% to 17% growth, and emphasizes a focus on executing new monetization strategies and scaling sales capacity to navigate market challenges.
See More
OpenAI Reportedly Building Internal Code Repository to Compete with GitHub
- Internal Repository Development: OpenAI is reportedly developing an internal code repository platform to lessen its reliance on Microsoft’s GitHub, a move partly triggered by recent outages that hindered developers' collaboration for hours, impacting project timelines and efficiency.
- Increased Market Competition: The project is still in its early stages and may take months to complete; if commercialized, it could position OpenAI in direct competition with Microsoft's developer ecosystem, despite their broader partnership.
- GitLab Earnings Performance: GitLab reported Q4 adjusted earnings of $0.30 per share, exceeding analyst expectations of $0.23, with revenue rising 23% year-over-year to $260.4 million, indicating strong growth in revenue generation.
- Cautious Future Outlook: Although GitLab's FY2026 revenue reached $955.2 million, up 26% from the previous year, its FY2027 adjusted earnings forecast of $0.76 to $0.80 per share is significantly below the consensus estimate of $1.03, leading to a decline in investor sentiment.
See More
GitLab's Fiscal 2027 Guidance Falls Short of Expectations
- Earnings Beat: GitLab reported adjusted EPS of $0.30 for Q4 FY2026, exceeding the $0.23 consensus estimate, with revenue rising 23% year-over-year to $260.4 million, indicating strong performance in the software development sector.
- Disappointing Guidance: The company projects FY2027 revenue midpoint at $1.11 billion, a 16% increase year-over-year, but below the $1.13 billion consensus, reflecting challenges in future growth prospects.
- Gross Margin Decline: GitLab anticipates a slight decline in gross margin for FY2027, expected to range from 85% to 87%, down from 89% in FY2026, which may affect investor confidence.
- Analyst Rating Adjustments: Several financial firms have lowered their price targets for GitLab, with Needham reducing its target from $50 to $32, indicating a cautious market outlook on the company's future growth despite maintaining a Buy rating.
See More
STAAR Surgical Reports Disappointing Q4 Results, Shares Plummet
- Disappointing Earnings: STAAR Surgical reported a fourth-quarter loss of $0.13 per share, significantly missing the analyst consensus estimate of a $0.06 profit, indicating major challenges in profitability.
- Sales Decline: The company's quarterly sales totaled $57.801 million, falling short of the analyst consensus estimate of $75.370 million, reflecting weak market demand and increased competitive pressure.
- Stock Reaction: In pre-market trading, STAAR Surgical's shares dropped 10.2% to $16.99, indicating investor concerns about the company's future prospects following the disappointing earnings report.
- Market Impact: This earnings report not only affects STAAR Surgical's stock price but may also negatively impact its market position in the medical device industry, prompting investors to monitor potential strategic adjustments going forward.
See More
GitLab Reports Strong Q4 but Weak FY2027 Guidance
- Strong Earnings Report: GitLab's Q4 EPS of 30 cents exceeded the consensus estimate of 23 cents, with revenue of $260.4 million growing 23% year-over-year, indicating robust performance in customer acquisition and revenue generation.
- Significant Customer Growth: The number of clients generating over $1 million in ARR rose 26% year-over-year to 155, demonstrating GitLab's success in attracting high-value customers and solidifying its market position.
- Weak Guidance Outlook: Despite achieving $955.2 million in revenue for FY2026, up 26%, the company's guidance for FY2027 adjusted EPS of 76 to 80 cents falls well below the $1.05 analyst estimate, leading to a bearish market sentiment.
- Stock Under Pressure: GitLab shares fell 9.85% to $24.07 in premarket trading, nearing a 52-week low of $23.45, reflecting investor concerns about future growth, with technical indicators suggesting a bearish trend in the short term.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, reflecting varying market perspectives that could influence investor decisions and market trends.
- Investor Focus: Analysts' opinions are particularly crucial when considering the purchase of SMTC stock, as these insights may affect investor confidence and willingness to buy, directly impacting stock prices.
- Source of Updates: A complete view of all analyst rating changes, including upgrades and downgrades, can be found on our analyst ratings page, providing a comprehensive perspective to help investors make informed decisions.
- Market Dynamics Impact: The adjustments in analysts' ratings not only reflect views on company fundamentals but may also influence overall market sentiment, subsequently affecting trading volumes and price fluctuations of related stocks.
See More
